NCT03362879
COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel
The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on levodopa-carbidopa intestinal gel (LCIG) monotherapy in a routine clinical setting.
The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on an active drug intestinal gel monotherapy in a routine clinical setting.